Stacy D Arnett

Title: Innovations of Inventor Stacy D Arnett

Introduction

Stacy D Arnett is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of biomedical research, particularly in the development of novel therapeutic agents. With a total of two patents to his name, his work focuses on addressing critical health challenges.

Latest Patents

One of his latest patents is titled "Fatty acid modified human epidermal growth factor." This patent provides new epidermal growth factor (EGF)-based reagents that have been modified by fatty acid conjugation. The disclosure also describes methods for using these agents to treat Short Bowel Syndrome (SBS). Another significant patent is "Alkenyl and beta-substituted phosphonates as antimicrobial agents." This patent relates to novel compounds, pharmaceutical compositions, and methods for treating or preventing microbial infections caused by parasites or bacteria, such as Plasmodium falciparum. The compounds are α,β-unsaturated analogs of fosmidomycin and can inhibit deoxyxylulose phosphate reductoisomerase (Dxr) in many microbes, including P. falciparum.

Career Highlights

Stacy D Arnett has worked with prestigious institutions, including Washington University and Saint Louis University. His research has contributed to advancements in medical treatments and has the potential to impact patient care significantly.

Collaborations

Some of his notable coworkers include Marvin Jay Meyers and Cynthia Dowd, who have collaborated with him on various research projects.

Conclusion

Stacy D Arnett's innovative work in the field of biomedical research showcases his commitment to developing new therapeutic solutions. His patents reflect a dedication to addressing significant health issues through scientific advancements.